We have been selected for the Nakanoshima Qross Drug Discovery and Commercialisation Promotion Programme Support Project.

We are pleased to announce that we have been selected for the Nakanoshima Qross Drug Discovery and Commercialisation Promotion Programme Support Project.

This initiative aims to rebuild and strengthen Japan's drug discovery capabilities by establishing a new, end-to-end support system specifically designed to commercialise drug discovery seeds held by startups and academia. This addresses challenges such as drug lag and drug loss.
Its primary objective is to connect diverse players including domestic and international pharmaceutical companies, venture capital firms, medical institutions, regulatory authorities, and local governments. This will foster the formation of a globally competitive drug discovery hub and accelerate the creation of innovative new drugs.
Please see the URL below for this project.
https://www.nakanoshima-qross.jp/en/news/2030/